CompletedNot Applicable

The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients

United States72 participantsStarted 2011-11

Plain-language summary

The proposed study is a pilot study and a first step towards developing an optimized HPV vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.

Who can participate

Age range9 Years – 18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 9-18-year-old girls who have CKD stages 3 or 4 (Glomerular filtration rates 15-59 mL/min/1.73m2). * 9-18-year-old girls who are on dialysis. * 9-18-year-old girls who have had a functioning kidney transplant for longer than 6 months and are on the same immunosuppression regimen. * Healthy 9-18-year-old girls Exclusion Criteria: * Pregnancy, fever, allergy to any vaccine component, any immune disorder and any blood product received in the previous 6 months.

Trial details

NCT IDNCT00767897

SponsorIndiana University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-12

View on ClinicalTrials.gov More Chronic Kidney Disease trials